Compare PRLB & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRLB | BCRX |
|---|---|---|
| Founded | 1999 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2011 | 1995 |
| Metric | PRLB | BCRX |
|---|---|---|
| Price | $89.76 | $8.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $53.00 | $20.82 |
| AVG Volume (30 Days) | 148.3K | ★ 3.7M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.33 | ★ 381.40 |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | $8.56 | N/A |
| Revenue Next Year | $6.89 | $12.55 |
| P/E Ratio | $123.49 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $45.10 | $6.00 |
| 52 Week High | $93.00 | $11.22 |
| Indicator | PRLB | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 63.96 | 46.31 |
| Support Level | $77.11 | $8.79 |
| Resistance Level | $93.00 | $9.31 |
| Average True Range (ATR) | 2.29 | 0.32 |
| MACD | 0.99 | -0.02 |
| Stochastic Oscillator | 87.30 | 40.04 |
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.